baber/WOPTO huggingface dataset:
Patent NZ-232757-A (NZ)
Title: Biodegradable film comprising a barrier material coated on or laminated to a starch-containing polymer film; ostomy bags made from such film
Inventor: ARONOFF MARVIN SAUL
IPC: B32B27/08
Filed: 1990-03-02
Abstract: Biodegradable composite films comprising a starch containing blended polymeric film and a barrier material coated or laminated to the blended film. The use of such composite films in ostomy pouches and other medical products is described. Also described is an ostomy pouch construction in which an adhesive label is affixed to the pouch so as to reduce the escape of odor from the stomal aperture.
Patent NZ-236881-A (NZ)
Title: Fluid circuit for timing control of pneumatically operated strapping tool
Inventor: TOPPEL ROBERT
IPC: B29C65/06
Filed: 1991-01-23
Abstract: A timing control circuit for a fluid pressure operable device (12) such as a strapping tool, is manually actuable to provide fluid flow to a reservoir (90) through a fluid-flow rate-controlling valve (80) from a supply (14). A line-pressure-operable, normally-open valve (60) is located in a primary fluid flow line (18) and this is closed when the pressure in the reservoir (90) builds up to the pressure to interrupt fluid flow to the device (12) to terminate its operation. <IMAGE>
Patent NZ-244247-A (NZ)
Title: Recovering volatile aroma constituents from gases evolved during processing of a beverage
Inventor: CARNS LAWRENCE G
IPC: A23F3/20
Filed: 1992-09-07
Abstract: Coffee aroma gases are conveyed to a cryogenic collector in which liquid nitrogen is sprayed directly into the aroma gas stream to rapidly condense the aroma gas and form finely divided particles of coffee aroma frost suspended in a stream of nitrogen gas, while minimizing contact of the cooled gas with the walls of the collector. The suspension of aroma frost particles in gaseous nitrogen is passed through a tubular porous filter to remove the aroma frost particles which collect on the outer surface of the tubular filter, with the nitrogen gas passing through the porous filter and being exhausted from the collector. The porous filter is periodically back pulsed to dislodge aroma frost particles collected on the outer surface of the tubular filter, with the particles being recovered for incorporation in soluble coffee products. <IMAGE>
Patent NZ-248207-A (NZ)
Title: Microspheres for prolonged release of lhrh hormone, preparation thereof
Inventor: BILLOT GENEVIEVE BERNADETTE
IPC: A61K47/34
Filed: 1993-07-20
Abstract: Process for the preparation of microspheres, for the prolonged release of the hormone LHRH and its analogues, the hormone being dispersed in a water-insoluble polymeric or copolymeric matrix, the solvent evaporation-based process is characterised by the use of a pair of organic solvents one of which makes it possible more specifically to obtain a homogeneous suspension of the hormone in the pulverulent state simply by stirring and the other of which is slightly miscible in water so as to allow more specifically the microdispersion of the organic phase in the aqueous phase in which the hardening of the microspheres is carried out. This process results in the preparation of LHRH-containing microspheres which are remarkable by virtue of their purity, especially in microspheres with a complex matrix, as well as in formulations comprising at least two types of microspheres.
Patent NZ-265624-A (NZ)
Title: Pyrimidinyl (oxy)/(thio)-acetaldehyde and acetic acid derivatives; intermediates; herbicides
Inventor: BAUMANN ERNST
IPC: C07D239/60
Filed: 1994-04-14
Abstract: PCT No. PCT/EP94/01156 Sec. 371 Date Oct. 19, 1995 Sec. 102(e) Date Oct. 19, 1995 PCT Filed Apr. 14, 1994 PCT Pub. No. WO94/25443 PCT Pub. Date Nov. 10, 19943-(Het)aryloxy(thio)carboxylic acid derivatives of the formula I    <IMAGE>  I  where R1 is hydrogen, COOH or a radical which can be hydrolyzed to give COOH; R2 and R3 are each halogen, alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; X is nitrogen or CR14, where R14 is hydrogen or, together with R3, forms a 3-membered or 4-membered alkylene or alkenylene chain, in each of which a methylene group is replaced by oxygen; R4 is alkyl, cycloalkyl, cycloalkenyl, alkenyl or alkynyl, each of which is unsubstituted or substituted; an unsubstituted or substituted five-membered or six-membered heteroaromatic structure containing one to three nitrogen atoms or one sulfur or oxygen atom; unsubstituted or substituted phenyl or naphthyl; R4 and R5, together with the neighboring carbon atom, form a 3-membered to 8-membered ring which may contain an oxygen or sulfur atom and which is unsubstituted or substituted; R5 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, haloalkyl, alkoxyalkyl, alkylthioalkyl or phenyl, each of which is unsubstituted or substituted; R6 is unsubstituted or substituted phenyl or naphthyl or an unsubstituted or substituted five-membered or six-membered heteroaromatic structure containing one to three nitrogen atoms or one sulfur or oxygen atom; Y is sulfur or oxygen or a single bond; and Z is sulfur or oxygen.
Patent NZ-293812-A (NZ)
Title: Preparation of (e)-2-(fluoromethylene)-4-(p-fluorophenyl)butan-1-ol and corresponding 1-amine
Inventor: EVANS JONATHAN CHARLES
IPC: A61K31/135
Filed: 1995-09-18
Abstract: The present invention relates to a novel process for preparing (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, also known in the art as (E)-(p-fluorophenethyl)-3-fluoroallylamine, and novel intermediates thereof (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane is useful as an irreversible inhibitor of monoamine oxidase.
Patent NZ-332736-A (NZ)
Title: Multicolor organic el element comprising organic dyes modified so they are capable of changing colours of light emitted from the element
Inventor: KIDO JUNJI
IPC: H01L51/30
Filed: 1997-05-14
Abstract: A multicolor organic EL element having a light emitting layer containing at least two organic dyes that can act as light emitting center (luminescence center), wherein at least one of said organic dyes is modified so as to change the colors of the light emitted from the element, and a method for manufacturing the element, and a display using the element. <IMAGE>
Patent NZ-332912-A (NZ)
Title: rinseable hard surface cleaner containing a silicate, a hydrophobic acrylic polymer and a surfactant
Inventor: LESKOWICZ JAMES J
IPC: C11D3/20
Filed: 1997-05-14
Abstract: This glass cleaner (or hard surface cleaner) comprises: a) n alkali metal or earth metal silicate, where the silicate is between .0000001% and 1%wt; b) a hydrophobic acrylic polymer that is between .000001% and 10% wt; and c) a surfactant that is at least .01%wt.
Patent NZ-337958-A (NZ)
Title: Motilin homolog designated zsig33 for treating gastrointestinal cell contractility, secretion of digestive enzymes, gastrointestinal motility, recruitment of digestive enzymes, reflux disease and regulation of nutrient absorption
Inventor: SHEPPARD PAUL O
IPC: C12N15/16
Filed: 1998-03-23
Abstract: An isolated polypeptide molecule encoding a polypeptide selected from the group consisting of nucleotide fragments selected from SEQ ID 1. The sequence is homologous to motilin. The composition is useful either as diagnosis agents for measuring transit time or gastric emptying or as agents which increase transient time or gastric emptying of ingested substances.
Patent NZ-505084-A (NZ)
Title: Method for treating sexual dysfunctions
IPC: A61K31/50
Filed: 1997-01-28
Abstract: A method for treating a sexual dysfunction in a subject, said method comprising administering an effective amount of a compound that enhances the stimulation of alpha-amino-3-hydoxy-5-methyl-isoxazole-4-propionic acid ("AMPA") receptors in said subject, said enhancement being sufficient to diminish the symptoms of sexual dysfunction.
Patent NZ-506626-A (NZ)
Title: Balance device for engine with journal portion having ribbed recessed section between adjacent full diameter sections
Inventor: IWATA KAZUYUKI
IPC: F16F15/26
Filed: 2000-08-30
Abstract: A pair of balancing shafts 19 have ribbed and recessed portions between two full diameter portions on respective journal sections.
Patent NZ-506854-A (NZ)
Title: Treatment of cardiac hypertrophy
Inventor: JIN HONGKUI
IPC: A61K31/38
Filed: 1999-03-19
Abstract: The use of interferon-gamma (IFN- ã) and therapeutic agents, such as â-adrenergic-blocking agents, verapamil, difedipine, diltiazem, in the manufacture of medicaments for the treatment of non-viral associated cardiac hypertrophy.
Patent NZ-509089-A (NZ)
Title: Affinity chromatography purification for production of mannan-binding lectin
Inventor: LAURSEN INGA
IPC: C07K14/47
Filed: 1999-06-10
Abstract: Described is a purification process in which the starting material is a supernatant, suspension, milk product, colostrum or crude plasma protein fraction containing MBL.  The starting material is subject to few pre-processing steps in order to obtain an MBL containing solution.  By this it is possible to perform an affinity chromatography as the first chromatographic process step employing a non-conjugated polysaccharide matrix, from which MBL of a high purity is eluted.  Besides constituting the major purification step of the process, the affinity chromatography also serves as a virus-removal step.  In the production process of a virus-safe product, a virus-inactivation step is also included.  The product of the process of the present invention is ready for use as medicinal product.
Patent NZ-510205-A (NZ)
Title: Process for the preparation of isoindoline involving catalytic hydrogenation of phthalonitrile
Inventor: SOUVIE JEAN-CLAUDE
IPC: C07D209/44
Filed: 2001-02-23
Abstract: A process for preparing isoindoline, an important intermediate compound, wherein a solution of phthalonitrile in either tetrahydrofuran, a mixture of tetrahydrofuran/water, or dimethoxyethane is subjected to hydrogen pressure, in the presence of Pt/C.
Patent NZ-510538-A (NZ)
Title: Sustained-release macrolide compositions for parenteral administration including a low HLB surfactant for treating parasite infections
Inventor: STEBER WILLIAM DAVID
IPC: A61K47/14
Filed: 2001-03-14
Abstract: A composition for parenteral administration which comprises on a weight to volume basis: 5-30% of a macrolide or a mixture of macrolides; 1-10% of a low-HLB surfactant or mixture of low-HLB surfactants; 1-20% of a co-solvent selected from the group consisting of an aromatic alcohol, a cyclic amide, and mixtures thereof; and a solvent selected from triglycerides of medium chain fatty acids, glycol esters of medium chain fatty acids and mixtures thereof. The compositions are useful for treating helminth, acarid or arthropod endo- or ectoparasitic infection or infestation in a warm blooded animal.
Patent NZ-510731-A (NZ)
Title: A phenolic resole-resorcinol novolac resin system with an extended pot life
Inventor: TAYLOR JOHN G
IPC: C08L61/12
Filed: 1999-09-21
Abstract: A fire resistant phenolic resole-resorcinol novolac system for a pultrusion process, having a much improved pot life of the two part mixture, lower emissions during processing and a much better surface finish of the pultruded composite when compared to a similar existing system. A method of making a phenolic resole for pultrusion including, but not limited to, the use of modified phenols such as p-phenyl phenol and nonyl phenol.
Patent NZ-511530-A (NZ)
Title: Method and apparatus for defeating high-velocity projectiles by use of imbricated pattern of tiles on backing sheet
Inventor: BAIN ALLAN D
IPC: B32B3/10
Filed: 1999-11-09
Abstract: A method and apparatus for defeating high-velocity projectiles is disclosed. A plurality of disks (52) of equal size and having a thickness greater at their centre than at their edge are laid out in an imbricated pattern, typically row by row such that each disk in a row is in substantially a straight line with the other disks in the row. The imbricated pattern is then adhered to a tear and cut resistant substrate and may be overlaid by a second high tensile strength layer (not shown) such that the imbricated pattern is enveloped between the substrate and the second layer.
Patent NZ-512638-A (NZ)
Title: Electromagnetic exposure chamber for improved heating
Inventor: JOINES WILLIAM T
IPC: H05B6/78
Filed: 1998-12-16
Abstract: Dielectric slabs are utilised to provide a relatively uniform electromagnetic field to a cavity between two or more dielectric slabs (12, 14).  Each dielectric slab is a thickness equal to or nearly equal to a quarter of a wavelength of the electromagnetic field in the dielectric slab.  In a particular embodiment, sample material is introduced into the cavity between the two dielectric slabs.  This sample material may be introduced through one or more openings in the dielectric slabs.  In further embodiments, specialised choke flanges prevent the leakage of energy from this cavity.  In a preferred embodiment, an elliptical conducting surface directs the electromagnetic field to a focal region between the two dielectric slabs.  Openings to this focal region allow sample material to be passed through this region of focused heating.
Patent NZ-528535-A (NZ)
Title: Personal storage system for storing data relating to a golf game
Inventor: FOSTER CHRISTOPHER CHARLES
Filed: 2003-09-26
Abstract: A system for a golf course for recording golf scores has two or more terminal positioned at various places on the golf course. The terminals are adapted to receive a portable storage medium carried by a golfer playing on the course, receive input indicating one or more scores of the golfer and store the one or more scores on the storage medium. The system also has a computer system adapted to receive the storage medium carried by the golfer and retrieve the scores stored on the storage medium.
Patent NZ-528663-A (NZ)
Title: Method for preparing 4-hydroxymethylpyrrolidin-3-ol compounds
Inventor: TYLER PETER CHARLES
IPC: C07D207/12
Filed: 2003-10-03
Abstract: A method of preparing (3R,4R)-3-hydroxy-4-hydroxymethylpyrrolidine of formula (A) and its enantiomer (3S,4S)-3-hydroxy-4-hydroxymethylpyrrolidine of formula (E) is disclosed, wherein the method includes a step of enzyme catalysed enantioselective esterification of a hydroxy group of a hydroxypyrroildine and separation of the diastereomers, wherein (3R,4R)-3-hydroxy-4-hydroxymethylpyrrolidine and (3S,4S)-3-hydroxy-4-hydroxymethylpyrrolidine are key intermediate compounds for the synthesis of certain inhibitor compounds.
Patent NZ-544504-A (NZ)
Title: Tobacco pouch with doubled adhesive closure tabs
Inventor: PATEL DEEPA
Filed: 2005-12-23
Abstract: A tobacco pouch is provided with two (or more) layered adhesive fastening tabs 8, 7. When the first tab 8 is "dirtied" after repeated use opening and closing the pouch it can be folded back and adhered behind the closure flap to expose the adhesive surface 15 of the second tab 7 that is then used to keep the flap closed to the pouch until all of the tobacco is used. A similar arrangement is known for use in repeated closing and opening of plastic surfaced disposable diapers.
Patent NZ-546178-A (NZ)
Title: Agent containing ergolin for transdermal application
Inventor: HOROWSKI REINHARD
IPC: A61K47/10
Filed: 2004-05-30
Abstract: Disclosed is an agent for transdermal application consisting of an impermeable top layer, a matrix containing ergolin compounds and, optionally, penetration-enhancing agents, an optional diffusion barrier covering the matrix, an adhesive layer that is permeable to these substances, and a peelable protective layer, characterized in that the ergolin compounds are stabilized by an antioxidant, which is selected from di-tert. -butyl methyl phenols, tert. -butyl methoxyphenols, tocopherols, and/or ubiquinones and a butyl methacrylate-2-(dimethylamino)ethyl-methacrylate-methacrylate copolymer.
Patent NZ-546437-A (NZ)
Title: Imidazopyridine-derivatives as inducible NO-synthase inhibitors
Inventor: ULRICH WOLF-RUEDIGER
IPC: A61K31/444
Filed: 2004-09-30
Abstract: Disclosed are imidazopyridine-derivatives of formula I, which act as inducible NO-synthase inhibitors, where the substituents A and R1-R5 are disclosed herein. Also disclosed is a pharmaceutical composition containing one or more compounds of formula I together with the usual pharmaceutical auxiliaries and/or excipients. The use of one or more compounds of formula I for the production of pharmaceutical compositions for the treatment of acute inflammatory diseases and chronic inflammatory diseases of peripheral organs and the CNS is further disclosed.
Patent NZ-546983-A (NZ)
Title: Reduction of dermal scarring
Inventor: GU DANLING
IPC: A61K38/00
Filed: 2004-11-23
Abstract: Provided is a use of a polynucleotide comprising an expression cassette for the manufacture of a medicament for reducing scarring in the skin or decreasing keloids of a subject having a wound, wherein the expression cassette comprises a promoter operably linked to a polynucleotide encoding p21 WAF1/CipI. Further provided are corresponding pharmaceutical compositions comprising the expression cassette formulated for topical application.
Patent NZ-560472-A (NZ)
Title: Lift belt with longitudinal wedge shaped ribs to engage the pulley and separated tensile carriers
Inventor: ACH ERNST
IPC: D07B1/22
Filed: 2007-08-08
Abstract: Lift belt (12) for a lift installation is disclosed. The belt (12) has a wedge rib (15) arrangement with at least two wedge ribs (15.1) which extend in longitudinal direction of the lift belt (12) and which form a contact side for engagement with a drive wheel of the lift installation. A tensile carrier arrangement with at least two tensile carriers (14.1) is arranged in two mutually adjacent wedge ribs (15.1) of the wedge rib arrangement (15). A back layer (13) which forms a rear side and is opposite the contact side of the lift belt forms a flat profile. At least one web (13.1) is formed integrally with the back layer (13) and projects from the back layer (13) into the wedge rib arrangement (15) towards the contact side and separates the tensile carriers (14.1) by material of the wedge rib arrangement (15).
Patent NZ-560804-A (NZ)
Title: Aptamer therapeutics useful in the treatment of complement-related disorders
Inventor: BENEDICT CLAUDE
IPC: C12N15/115
Filed: 2006-02-14
Abstract: Provided is a composition comprising a therapeutically effective amount of an aptamer having a specified nucleotide sequence or a salt of the aptamer, and having a polyethylene glycol moiety of 40kDa conjugated via a linker to the aptamer. The aptamers and their variants are useful as medicaments for myocardial injuries and transplant rejection.
Patent NZ-563120-A (NZ)
Title: Bituminous products, the mixture thereof with aggregates and the use thereof
Inventor: BARRETO GILLES
IPC: C09K23/00
Filed: 2006-04-04
Abstract: Disclosed is an anhydrous bituminous product, containing at least one of the following additives: A: the product resulting from the reaction of alkyl, dialkyl, alkenyl or dialkenyl phenols on aldehydes, the aldehydes having from 1 to 10 carbon atoms, followed by a (poly) oxyethylation and/or (poly) oxypropylation, the alk(en)yl groups having between 1 and 50 carbon atoms, and able to be identical or different in the case of dialkyl phenols or dialkenyl phenols, the part formed by (poly) oxyethylation and/or (poly) oxypropylation having a molar mass of not less than 45 g/mol and not more than 20,000 g /mol, the number of phenolic units of product A varying between 3 and 50; B: a (poly) oxyethylated and/or (poly) oxy propylated 2, 2-bis (4-hydroxyphenyl)propane/epichlorohydrin copolymer, the part formed by (poly) oxyethylation and/or (poly) oxypropylation having a molar mass of not less than 45 g/mol and not more than 20,000 g/mol; C: a (poly) oxyethylated and/or (poly) oxy propylated bis(4-hydroxyphenyl) ethane/epichiorohydrin copolymer, the part formed by (poly)oxyethylation and/or (poly)oxypropylation having a molar mass of not less than 45 g/mol and not more than 20,000 g/mol; D: a (poly)oxyethylated and/or (poly)oxy propylated bis (4-hydroxyphenyl) methane/epichlorohydrin copolymer, the part formed by (poly)oxyethylation and/or (poly)oxypropylation having a molar mass of not less than 45 g/mol and not more than 20,000 g/mol; E: the product resulting from the (poly)oxyethylation and/or (poly)oxypropylation of an alkyldicarboxylic acid or mixture of alkyldicarboxylic acids, the alkyl groups having between 1 and 20, all the parts formed by (poly)oxyethylation and/or (poly)oxypropylation having a molar mass of not less than 100 g/mol and not more than 20,000 g/mol; F: the product resulting from the (poly)oxyethylation and/or (poly) oxypropylation of a fatty acid, the number of carbon atoms of which is between 10 and 30, the part formed by (poly)oxyethylation and/or (poly)oxypropylation having a molar mass of not less than 100 g/mol and not more than 20,000 g/mol; G: the product resulting from the reaction between product A and the mixture of products E and F; H: a salt obtained from an alkyl (aryl) sulphonic or alkenyl (aryl) sulphonic acid and an alkyl (aryl) amine or alkenyl (aryl) amine the alkyl (aryl) or alkenyl (aryl) units having a number of carbon atoms between 6 and 30; and I: a salt formed from an alkyl (aryl) sulphonic or alkenyl (aryl) sulphonic acid and morpholine or pyrazine or pyrazoline or pyrazolone or pyridine or pyridone or pyrimidine or pyrrole or pyrrolidine or pyrrolidone or pyrroline or toluidine or imidazole or indol or indoline or oxindole, the alkyl (aryl) or alkenyl (aryl) units having a number of carbon atoms of between 6 and 30.
Patent NZ-563433-A (NZ)
Title: Erythropoietin receptor peptide formulations and uses
Inventor: DULIEGE ANNE-MARIE
IPC: A01N37/18
Filed: 2006-06-05
Abstract: Provided is the use of a compound that binds to and activates the erythropoietin receptor (EPO-R), wherein the compound comprises: (a) a peptide dimer moiety comprising a first peptide monomer and a second peptide monomer, wherein the first and second peptide monomer comprise the amino acid sequence (AcG)GLYACHMGPIT(1-nal)VCQPLR; (b) a linker moiety covalently bonding said peptide monomers; (c) at least one poly(ethylene glycol) (PEG) moiety comprising a linear, unbranched PEG having molecular weight of 10,000 to 60,000 Daltons; and (d) a spacer moiety covalently joining said at least one PEG moiety to said linker moiety and having a specified formula.
Patent NZ-578411-A (NZ)
Title: Nicotinic acetylcholine receptor modulators
Inventor: GHIRON CHIARA
IPC: A61K31/4155
Filed: 2008-01-16
Abstract: Disclosed herein is a compound of formula (I) wherein the substituents are defined within the specification, pharmaceutical compositions comprising said compounds and process for their preparation. Such compounds are useful alpha-7 nicotinic acetylcholine receptor (alpha7 nAChR) agonistic activity, and therefore are useful in the treatment of neurological, neurodegenereative, psychiatric, cognitive, immunological, inflammatory, metabolic, addiction, nociceptive and sexual disorders.
Patent NZ-581781-A (NZ)
Title: A method of treating myiasis of an animal
Inventor: TAYLOR WENDY SUE
IPC: A01P7/04
Filed: 2008-07-28
Abstract: Disclosed is a method of treating myiasis of a non-human animal by applying to the animal a composition comprising an parasiticidally effective amount of a compound of Formula 1.
Patent NZ-589693-A (NZ)
Title: Container for foodstuff cooling with a central apertured shaft
Inventor: FLOREY LYNDA KAY
IPC: B65D81/24
Filed: 2010-01-20
Abstract: A container having an upright shaft 6 which proceeds from a position at or adjacent to the base of the container to a position at or adjacent the top of the container. The shaft 6 is located in an inner medial part of the container. The shaft 6 has a plurality of apertures 5 open to a foodstuff when filled into the container such that heat from the foodstuff can vent into the shaft 6 via the apertures 5 and then out of the shaft 6 via an opening in an upper part of the shaft 6. The fill of foodstuff is being or has been cooled by the heat from the foodstuff venting into and then out of the shaft 6.